News | March 26, 2015

SCAI Unveils Highlights for 2015 Scientific Sessions

Key topics will include emerging technologies, cardiac cath lab strategies and the latest clinical research

SCAI, 2015, Scientific Sessions, highlights, angiography

March 26, 2015 — The Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will take place May 6-9 in San Diego, California. SCAI 2015 will deliver updates affecting the invasive/interventional cardiovascular field, including late-breaking clinical trials; keynote addresses; and practice-relevant education for diagnosing and treating patients with congenital, coronary, peripheral and structural heart disease.

The SCAI 2015 keynote lecturers will include:

  • Peter J. Fitzgerald, M.D., Ph.D., and Christian Assad-Kottner, M.D., who will open the conference with a new session focused on how new and emerging technologies have the potential to transform every aspect of cardiovascular care. 
  • Robert Harrington, M.D., FSCAI, who will focus on the critical need for more clinical research in interventional cardiology, simplification of larger trials, better early-phase investigations and the use of electronic health records to ease the path to new research. His lecture, “The Future of Clinical Research in Interventional Cardiology: Challenges and Opportunities,” will be held Friday, May 8.
  • Joseph Loscalzo, M.D., Ph.D., sharing how advances in big data are helping to unlock some of the complexities of congenital heart disease, uncover the complex pathways that influence disease and providing the promise of new, personalized treatments. He will present his address, “Network Medicine:  A Systems Approach to Cardiovascular Disease Diagnosis and Management,” on Thursday, May 7.

SCAI 2015 will also feature –

  • SCAI’s Cath Lab Leadership Boot Camp, where cardiac cath lab teams will learn strategies for working collaboratively to deliver high-quality, appropriate care while reducing cost and improving resource utilization.
  • MOC Requirements & Controversies, where faculty and attendees will debate the role and maintenance of certification in interventional cardiologists’ lifelong learning.
  • How to Treat Critically Ill Patients, a pair of sessions focused on cardiogenic shock, including one offered jointly with the Heart Failure Society of America.


For more information:

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init